Bio-Works Technologies AB (FRA:1BD) Institutional Ownership: 0.26% (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1BD Bio-Works Technologies AB FRA:1BD
49 GF Score
Price €0.29
GF Value €0.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bio-Works Technologies AB Institutional Ownership?

Bio-Works Technologies AB FRA:1BD +0.35% 49 Institutional Ownership is 0.26% as of Aug. 22, 2026. GuruFocus rates FRA:1BD with a GF Score™ of 49/100 and a GF Value™ of €0.32 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bio-Works Technologies AB's institutional ownership is 0.26%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bio-Works Technologies AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bio-Works Technologies AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Bio-Works Technologies AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Bio-Works Technologies AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Works Technologies AB Institutional Ownership Chart

Bio-Works Technologies AB Historical Data

The historical data trend for Bio-Works Technologies AB can be seen below:

2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30
Institutional Ownership 3.33 3.33 3.21 3.19 3.07 3.05 2.78 2.68 0.29 0.26
FRA:1BD
49GF Score
Bio-Works Technologies AB FRA:1BD
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Works Technologies AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.26% mean?
Bio-Works Technologies AB (FRA:1BD) has a Institutional Ownership of 0.26% as of Aug. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bio-Works Technologies AB and its competitors.
Is Bio-Works Technologies AB's Institutional Ownership too high?
Bio-Works Technologies AB's current Institutional Ownership is 0.26%. Overall, Bio-Works Technologies AB has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bio-Works Technologies AB's Institutional Ownership compare to ISRG and BDX?
Bio-Works Technologies AB's Institutional Ownership of 0.26% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Bio-Works Technologies AB and its competitors. Bio-Works Technologies AB's current Institutional Ownership is 0.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Works Technologies AB stock overvalued right now?
Based on GuruFocus' analysis, Bio-Works Technologies AB (FRA:1BD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.32, compared to a current price of €0.29 — trading 10.3% below its estimated fair value. The current Institutional Ownership is 0.26%. Bio-Works Technologies AB's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Bio-Works Technologies AB (FRA:1BD), the current Institutional Ownership is 0.26% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Works Technologies AB (FRA:1BD) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Works Technologies AB stock appears to be undervalued. The current stock price of €0.29 is trading 10.3% below its estimated GF Value™ of €0.32. GuruFocus considers Bio-Works Technologies AB to be Modestly Undervalued.

Key valuation signals for FRA:1BD:

  • Institutional Ownership: 0.26%
  • GF Value™: €0.32 vs. price of €0.29 (10.3% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the FRA:1BD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Works Technologies AB Business Description

Other Exchanges BIOWKS:Sweden
Address Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
49GF Score

Get the complete analysis for FRA:1BD

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.32
GF Value